Health Ministry Data

Showing 2881 articles
Business

Idorsia's Latin American Gambit: QUVIVIQ Deal with EMS Signals Strategic Shift Amid Pipeline Scrutiny

Idorsia's exclusive licensing agreement with EMS to commercialize insomnia drug QUVIVIQ across Latin America marks a key step in its global expansion. The deal, involving $20 million in milestones and royalties, arrives as long-term data for its Fabry disease candidate lucerastat puts the spotlight on the company's broader late-stage pipeline and persistent financial pressures.

World

South Africa and Israel expel envoys in deepening feud

South Africa ordered Israel's top diplomat to leave the country within 72 hours on Friday, citing a "series of violations" and prompting the Israeli government to expel Pretoria's own diplomatic representative.The Israeli foreign ministry swiftly responded that South Africa's senior diplomatic representative, Shaun Byneveldt, "is persona non grata and must leave Israel within 72 hours".

Business

CLEAR Secure Expands Government Footprint: CEO Joins NY Fed Board, Lands Major Medicare Identity Verification Contract

CLEAR Secure, the biometric identity company known for its airport expedited lanes, is deepening its ties to core government systems. CEO Caryn Seidman Becker's appointment to the Federal Reserve Bank of New York's board and a new contract with the Centers for Medicare & Medicaid Services signal a strategic push into financial and public health infrastructure.

Business

Medical Properties Trust Sees Surge in Options Bets Ahead of Earnings, Spotlight on Turnaround Hopes

Ahead of its February 26 earnings report, Medical Properties Trust (NYSE: MPW) is witnessing a notable spike in options activity, with call volume soaring to roughly five times its usual level. This surge in speculative interest comes as the healthcare REIT's shares hover around $5.05, showing recent momentum but still grappling with a challenging multi-year performance. Analysts are divided on whether the stock's current price reflects lingering past troubles or is beginning to price in a potential recovery narrative.